Silverfin false true 31/12/2025 01/01/2025 31/12/2025 I Birtles 23/06/2016 J McElgunn 22/01/2024 T Meller 22/01/2024 14 September 2026 no description of principal activity 10248761 2025-12-31 10248761 bus:Director1 2025-12-31 10248761 bus:Director2 2025-12-31 10248761 bus:Director3 2025-12-31 10248761 2024-12-31 10248761 core:ShareCapital 2025-12-31 10248761 core:ShareCapital 2024-12-31 10248761 core:RetainedEarningsAccumulatedLosses 2025-12-31 10248761 core:RetainedEarningsAccumulatedLosses 2024-12-31 10248761 core:CostValuation 2024-12-31 10248761 core:CostValuation 2025-12-31 10248761 bus:OrdinaryShareClass1 2025-12-31 10248761 2025-01-01 2025-12-31 10248761 bus:FilletedAccounts 2025-01-01 2025-12-31 10248761 bus:SmallEntities 2025-01-01 2025-12-31 10248761 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 10248761 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10248761 bus:Director1 2025-01-01 2025-12-31 10248761 bus:Director2 2025-01-01 2025-12-31 10248761 bus:Director3 2025-01-01 2025-12-31 10248761 2024-01-01 2024-12-31 10248761 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 10248761 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 10248761 1 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 10248761 (England and Wales)

RSHP3 LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

RSHP3 LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

RSHP3 LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2025
RSHP3 LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2025
DIRECTORS I Birtles
J McElgunn
T Meller
REGISTERED OFFICE Level 14 The Leadenhall Building
122 Leadenhall Street
London
EC3V 4AB
United Kingdom
COMPANY NUMBER 10248761 (England and Wales)
ACCOUNTANT Praxis
1 Fore Street Avenue
London
EC2Y 9DT
RSHP3 LIMITED

BALANCE SHEET

As at 31 December 2025
RSHP3 LIMITED

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Current assets
Cash at bank and in hand 4 4 4
4 4
Net current assets 4 4
Total assets less current liabilities 4 4
Net assets 4 4
Capital and reserves
Called-up share capital 5 100 100
Profit and loss account ( 96 ) ( 96 )
Total shareholder's funds 4 4

RSHP3 Limited (registered number: 10248761) did not trade during the current or preceding financial year and has made neither profit nor loss, nor any other comprehensive income. There have been no movements in shareholders’ funds during the current or preceding financial year and therefore no Statement of Changes in Equity has been included. For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The financial statements of RSHP3 Limited (registered number: 10248761) were approved and authorised for issue by the Board of Directors on 14 September 2026. They were signed on its behalf by:

I Birtles
Director
RSHP3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
RSHP3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

RSHP3 Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Level 14 The Leadenhall Building, 122 Leadenhall Street, London, EC3V 4AB, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 January 2025 0 0
At 31 December 2025 0 0
Carrying value at 31 December 2025 0 0
Carrying value at 31 December 2024 0 0

The Company is a member of RSHP LLP, with no capital, voting rights or profit shares.

4. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 4 4

5. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100

6. Ultimate controlling party

Parent Company:

RSHP Holdings Limited
Level 14, The Leadenhall Building, 122 Leadenhall Street, London, United Kingdom, EC3V 4AB.

The ultimate parent entity is RSHP Group Limited, a company registered in England and Wales with a registered number of 01698321. The registered office of RSHP Group Limited is Level 14, The Leadenhall Building, 122 Leadenhall Street, London, United Kingdom, EC3V 4AB

The largest and smallest group of undertakings for which consolidated accounts are drawn up and in which the Company is included is the group headed by RSHP Group Limited. Copies of these accounts can be obtained from Companies House, Crown Way, Cardiff.